Two-in-One Cancer Test Is the First of Its Kind Mar 09, 2022 The blood-based test is the first ever to simultaneously identify if a patient has cancer and if it has spread. Medtronic Recalls TurboHawk Due to HawkOne Recall Mar 09, 2022 After recalling the HawkOne Directional Atherectomy System earlier this year, Medtronic is also recalling (correcting) its TurboHawk Plus Directional Atherectomy System due to design similarities with the HawkOne. Roche Launches Its Smallest Molecular System in UK Mar 09, 2022 The new system has a smaller footprint, and is fully automated to improve testing volumes, and operational efficiency. Axonics Closes a Portfolio Gap in Sacral Neuromodulation Mar 09, 2022 FDA approval of a recharge-free system could drive additional market share gains for Medtronic's sole competitor in the sacral nueromodulation space. Sherlock Raises $80M to Solve Diagnostic Barrier Dilemma Mar 08, 2022 With this latest financing, the Boston, MA-based company has now raised a total of $111 million. A New Challenger Has Entered the (U.S.) SCS Market Mar 08, 2022 Saluda Medical has won FDA approval for its Evoke Spinal Cord Stimulation System. Medtech in a Minute: J&J Changes the Contact Lens Game, and More Mar 07, 2022 Quickly catch up on the latest medtech news from Johnson & Johnson, Dexcom, Pear Therapeutics, and Others A Wearable Vein Dilation Device Wins Breakthrough Designation Mar 05, 2022 A vascular surgeon needed a better way to make patients’ veins bigger to prepare them for dialysis. So he invented one. Dexcom Wants to Take its CGM Technology to the Hospital Setting Mar 03, 2022 The San Diego, CA-based company won breakthrough device designation for its CGMs to be used in the hospital setting. ‘The Dropout’: Binge Worthy or Don’t Bother? Mar 03, 2022 Starring Amanda Seyfried as Elizabeth Holmes, “The Dropout” is Hulu’s limited series about the unbelievable rise and fall of Theranos. Load More first previous � 6 7 8 9 10 11 12 13 14 next last Load More
Medtronic Recalls TurboHawk Due to HawkOne Recall Mar 09, 2022 After recalling the HawkOne Directional Atherectomy System earlier this year, Medtronic is also recalling (correcting) its TurboHawk Plus Directional Atherectomy System due to design similarities with the HawkOne. Roche Launches Its Smallest Molecular System in UK Mar 09, 2022 The new system has a smaller footprint, and is fully automated to improve testing volumes, and operational efficiency. Axonics Closes a Portfolio Gap in Sacral Neuromodulation Mar 09, 2022 FDA approval of a recharge-free system could drive additional market share gains for Medtronic's sole competitor in the sacral nueromodulation space. Sherlock Raises $80M to Solve Diagnostic Barrier Dilemma Mar 08, 2022 With this latest financing, the Boston, MA-based company has now raised a total of $111 million. A New Challenger Has Entered the (U.S.) SCS Market Mar 08, 2022 Saluda Medical has won FDA approval for its Evoke Spinal Cord Stimulation System. Medtech in a Minute: J&J Changes the Contact Lens Game, and More Mar 07, 2022 Quickly catch up on the latest medtech news from Johnson & Johnson, Dexcom, Pear Therapeutics, and Others A Wearable Vein Dilation Device Wins Breakthrough Designation Mar 05, 2022 A vascular surgeon needed a better way to make patients’ veins bigger to prepare them for dialysis. So he invented one. Dexcom Wants to Take its CGM Technology to the Hospital Setting Mar 03, 2022 The San Diego, CA-based company won breakthrough device designation for its CGMs to be used in the hospital setting. ‘The Dropout’: Binge Worthy or Don’t Bother? Mar 03, 2022 Starring Amanda Seyfried as Elizabeth Holmes, “The Dropout” is Hulu’s limited series about the unbelievable rise and fall of Theranos. Load More first previous � 6 7 8 9 10 11 12 13 14 next last Load More
Roche Launches Its Smallest Molecular System in UK Mar 09, 2022 The new system has a smaller footprint, and is fully automated to improve testing volumes, and operational efficiency. Axonics Closes a Portfolio Gap in Sacral Neuromodulation Mar 09, 2022 FDA approval of a recharge-free system could drive additional market share gains for Medtronic's sole competitor in the sacral nueromodulation space. Sherlock Raises $80M to Solve Diagnostic Barrier Dilemma Mar 08, 2022 With this latest financing, the Boston, MA-based company has now raised a total of $111 million. A New Challenger Has Entered the (U.S.) SCS Market Mar 08, 2022 Saluda Medical has won FDA approval for its Evoke Spinal Cord Stimulation System. Medtech in a Minute: J&J Changes the Contact Lens Game, and More Mar 07, 2022 Quickly catch up on the latest medtech news from Johnson & Johnson, Dexcom, Pear Therapeutics, and Others A Wearable Vein Dilation Device Wins Breakthrough Designation Mar 05, 2022 A vascular surgeon needed a better way to make patients’ veins bigger to prepare them for dialysis. So he invented one. Dexcom Wants to Take its CGM Technology to the Hospital Setting Mar 03, 2022 The San Diego, CA-based company won breakthrough device designation for its CGMs to be used in the hospital setting. ‘The Dropout’: Binge Worthy or Don’t Bother? Mar 03, 2022 Starring Amanda Seyfried as Elizabeth Holmes, “The Dropout” is Hulu’s limited series about the unbelievable rise and fall of Theranos. Load More first previous � 6 7 8 9 10 11 12 13 14 next last Load More
Axonics Closes a Portfolio Gap in Sacral Neuromodulation Mar 09, 2022 FDA approval of a recharge-free system could drive additional market share gains for Medtronic's sole competitor in the sacral nueromodulation space. Sherlock Raises $80M to Solve Diagnostic Barrier Dilemma Mar 08, 2022 With this latest financing, the Boston, MA-based company has now raised a total of $111 million. A New Challenger Has Entered the (U.S.) SCS Market Mar 08, 2022 Saluda Medical has won FDA approval for its Evoke Spinal Cord Stimulation System. Medtech in a Minute: J&J Changes the Contact Lens Game, and More Mar 07, 2022 Quickly catch up on the latest medtech news from Johnson & Johnson, Dexcom, Pear Therapeutics, and Others A Wearable Vein Dilation Device Wins Breakthrough Designation Mar 05, 2022 A vascular surgeon needed a better way to make patients’ veins bigger to prepare them for dialysis. So he invented one. Dexcom Wants to Take its CGM Technology to the Hospital Setting Mar 03, 2022 The San Diego, CA-based company won breakthrough device designation for its CGMs to be used in the hospital setting. ‘The Dropout’: Binge Worthy or Don’t Bother? Mar 03, 2022 Starring Amanda Seyfried as Elizabeth Holmes, “The Dropout” is Hulu’s limited series about the unbelievable rise and fall of Theranos. Load More first previous � 6 7 8 9 10 11 12 13 14 next last Load More
Sherlock Raises $80M to Solve Diagnostic Barrier Dilemma Mar 08, 2022 With this latest financing, the Boston, MA-based company has now raised a total of $111 million. A New Challenger Has Entered the (U.S.) SCS Market Mar 08, 2022 Saluda Medical has won FDA approval for its Evoke Spinal Cord Stimulation System. Medtech in a Minute: J&J Changes the Contact Lens Game, and More Mar 07, 2022 Quickly catch up on the latest medtech news from Johnson & Johnson, Dexcom, Pear Therapeutics, and Others A Wearable Vein Dilation Device Wins Breakthrough Designation Mar 05, 2022 A vascular surgeon needed a better way to make patients’ veins bigger to prepare them for dialysis. So he invented one. Dexcom Wants to Take its CGM Technology to the Hospital Setting Mar 03, 2022 The San Diego, CA-based company won breakthrough device designation for its CGMs to be used in the hospital setting. ‘The Dropout’: Binge Worthy or Don’t Bother? Mar 03, 2022 Starring Amanda Seyfried as Elizabeth Holmes, “The Dropout” is Hulu’s limited series about the unbelievable rise and fall of Theranos. Load More first previous � 6 7 8 9 10 11 12 13 14 next last Load More
A New Challenger Has Entered the (U.S.) SCS Market Mar 08, 2022 Saluda Medical has won FDA approval for its Evoke Spinal Cord Stimulation System. Medtech in a Minute: J&J Changes the Contact Lens Game, and More Mar 07, 2022 Quickly catch up on the latest medtech news from Johnson & Johnson, Dexcom, Pear Therapeutics, and Others A Wearable Vein Dilation Device Wins Breakthrough Designation Mar 05, 2022 A vascular surgeon needed a better way to make patients’ veins bigger to prepare them for dialysis. So he invented one. Dexcom Wants to Take its CGM Technology to the Hospital Setting Mar 03, 2022 The San Diego, CA-based company won breakthrough device designation for its CGMs to be used in the hospital setting. ‘The Dropout’: Binge Worthy or Don’t Bother? Mar 03, 2022 Starring Amanda Seyfried as Elizabeth Holmes, “The Dropout” is Hulu’s limited series about the unbelievable rise and fall of Theranos. Load More first previous � 6 7 8 9 10 11 12 13 14 next last Load More
Medtech in a Minute: J&J Changes the Contact Lens Game, and More Mar 07, 2022 Quickly catch up on the latest medtech news from Johnson & Johnson, Dexcom, Pear Therapeutics, and Others A Wearable Vein Dilation Device Wins Breakthrough Designation Mar 05, 2022 A vascular surgeon needed a better way to make patients’ veins bigger to prepare them for dialysis. So he invented one. Dexcom Wants to Take its CGM Technology to the Hospital Setting Mar 03, 2022 The San Diego, CA-based company won breakthrough device designation for its CGMs to be used in the hospital setting. ‘The Dropout’: Binge Worthy or Don’t Bother? Mar 03, 2022 Starring Amanda Seyfried as Elizabeth Holmes, “The Dropout” is Hulu’s limited series about the unbelievable rise and fall of Theranos. Load More first previous � 6 7 8 9 10 11 12 13 14 next last Load More
A Wearable Vein Dilation Device Wins Breakthrough Designation Mar 05, 2022 A vascular surgeon needed a better way to make patients’ veins bigger to prepare them for dialysis. So he invented one. Dexcom Wants to Take its CGM Technology to the Hospital Setting Mar 03, 2022 The San Diego, CA-based company won breakthrough device designation for its CGMs to be used in the hospital setting. ‘The Dropout’: Binge Worthy or Don’t Bother? Mar 03, 2022 Starring Amanda Seyfried as Elizabeth Holmes, “The Dropout” is Hulu’s limited series about the unbelievable rise and fall of Theranos. Load More first previous � 6 7 8 9 10 11 12 13 14 next last Load More
Dexcom Wants to Take its CGM Technology to the Hospital Setting Mar 03, 2022 The San Diego, CA-based company won breakthrough device designation for its CGMs to be used in the hospital setting. ‘The Dropout’: Binge Worthy or Don’t Bother? Mar 03, 2022 Starring Amanda Seyfried as Elizabeth Holmes, “The Dropout” is Hulu’s limited series about the unbelievable rise and fall of Theranos. Load More first previous � 6 7 8 9 10 11 12 13 14 next last Load More
‘The Dropout’: Binge Worthy or Don’t Bother? Mar 03, 2022 Starring Amanda Seyfried as Elizabeth Holmes, “The Dropout” is Hulu’s limited series about the unbelievable rise and fall of Theranos. Load More first previous � 6 7 8 9 10 11 12 13 14 next last Load More
